Scott Jonathan Ayton (S Ayton, Scott Ayton, Scott J Ayton)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 40

Top Topics

Cerebrospinal Fluid

Positive Breast Cancer

Duchenne Muscular Dystrophy

Cognitive Decline

Top Venues

Molecular psychiatry

International journal of molecular sciences

Brain communications

This page only lists publications with an associated author ORCID identifier.

Publications

Aadya Nagpal, Kristen Needham, Darius J R Lane, Scott Jonathan Ayton, Richard P Redvers, Melissa John, Heloisa S Selistre-de-Araujo, Delphine Denoyer, Normand Pouliot
Integrin αvβ3 Is a Master Regulator of Resistance to TKI-Induced Ferroptosis in HER2-Positive Breast Cancer. Cancers 15 (4) (2023)
Amit Lotan, Sandra Luza, Carlos M Opazo, Scott Jonathan Ayton, Darius J R Lane, Serafino Mancuso, Avril Pereira, Suresh Sundram, Cynthia Shannon Weickert, Chad A Bousman, Christos Pantelis, Ian P Everall, Ashley I Bush
Perturbed iron biology in the prefrontal cortex of people with schizophrenia. Molecular psychiatry (2023)
Amit Lotan, Sandra Luza, Carlos M Opazo, Scott Jonathan Ayton, Darius J R Lane, Serafino Mancuso, Avril Pereira, Suresh Sundram, Cynthia Shannon Weickert, Chad A Bousman, Christos Pantelis, Ian P Everall, Ashley I Bush
Perturbed iron biology in the prefrontal cortex of people with schizophrenia. Molecular psychiatry (2023)
Salvatore P Mangiafico, Qing-Zhang Tuo, Xiao-Lan Li, Yu Liu, Christian Haralambous, Xu-Long Ding, Scott Jonathan Ayton, Qing Wang, D Ross Laybutt, Jeng Yie Chan, Xiang Zhang, Cameron Kos, Helen E Thomas, Thomas Loudovaris, Chieh-Hsin Yang, Christos N Joannides, Benjamin J Lamont, Lunzhi Dai, Hai-Huai He, Biao Dong, Sofianos Andrikopoulos, Ashley I Bush, Peng Lei
Tau suppresses microtubule-regulated pancreatic insulin secretion. Molecular psychiatry (2023)
Kathy Y Liu, Nicolas Villain, Scott Jonathan Ayton, Sarah F Ackley, Vincent Planche, Robert Howard, Madhav Thambisetty
Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer's disease. Brain communications 5 (3) (2023)
Kathy Y Liu, Nicolas Villain, Scott Jonathan Ayton, Sarah F Ackley, Vincent Planche, Robert Howard, Madhav Thambisetty
Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer's disease. Brain communications 5 (3) (2023)
Sixin Liu, Catherine A Butler, Scott Jonathan Ayton, Eric C Reynolds, Stuart G Dashper
Porphyromonas gingivalis and the pathogenesis of Alzheimer's disease. Critical reviews in microbiology (2023)
Aadya Nagpal, Kristen Needham, Darius J R Lane, Scott Jonathan Ayton, Richard P Redvers, Melissa John, Heloisa S Selistre-de-Araujo, Delphine Denoyer, Normand Pouliot
Integrin αvβ3 Is a Master Regulator of Resistance to TKI-Induced Ferroptosis in HER2-Positive Breast Cancer. Cancers 15 (4) (2023)
Amit Lotan, Sandra Luza, Carlos M Opazo, Scott Jonathan Ayton, Darius J R Lane, Serafino Mancuso, Avril Pereira, Suresh Sundram, Cynthia Shannon Weickert, Chad A Bousman, Christos Pantelis, Ian P Everall, Ashley I Bush
Perturbed iron biology in the prefrontal cortex of people with schizophrenia. Molecular psychiatry (2023)
Aadya Nagpal, Kristen Needham, Darius J R Lane, Scott Jonathan Ayton, Richard P Redvers, Melissa John, Heloisa S Selistre-de-Araujo, Delphine Denoyer, Normand Pouliot
Integrin αvβ3 Is a Master Regulator of Resistance to TKI-Induced Ferroptosis in HER2-Positive Breast Cancer. Cancers 15 (4) (2023)
Kathy Y Liu, Nicolas Villain, Scott Jonathan Ayton, Sarah F Ackley, Vincent Planche, Robert Howard, Madhav Thambisetty
Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer's disease. Brain communications 5 (3) (2023)
Lachlan F Miles, Yugeesh R Lankadeva, Robert D Sanders, Scott Jonathan Ayton
Neurofilament Light and Cognition after Cardiac Surgery: Comment. Anesthesiology (2023)
Abdel Ali Belaidi, Shashank Masaldan, Adam Southon, Pawel Kalinowski, Karla Acevedo, Ambili T Appukuttan, Stuart Portbury, Peng Lei, Puja Agarwal, Sue E Leurgans, Julie Schneider, Marcus Conrad, Ashley I Bush, Scott Jonathan Ayton
Apolipoprotein E potently inhibits ferroptosis by blocking ferritinophagy. Molecular psychiatry (2022)
Pravat Kumar Mandal, Anshika Goel, Ashley I Bush, Khushboo Punjabi, Shallu Joon, Ritwick Mishra, Manjari Tripathi, Arun Garg, Natasha K Kumar, Pooja Sharma, Deepika Shukla, Scott Jonathan Ayton, Amir Fazlollahi, Joseph C Maroon, Divya Dwivedi, Avantika Samkaria, Kanika Sandal, Kanu Megha, Sandhya Shandilya
Hippocampal glutathione depletion with enhanced iron level in patients with mild cognitive impairment and Alzheimer's disease compared with healthy elderly participants. Brain communications 4 (5) (2022)
Md Jakaria, Abdel Ali Belaidi, Adam Southon, Krista A Dent, Darius J R Lane, Ashley I Bush, Scott Jonathan Ayton
Receptor-Independent Anti-Ferroptotic Activity of TrkB Modulators. International journal of molecular sciences 23 (24) (2022)
Md Jakaria, Abdel Ali Belaidi, Adam Southon, Krista A Dent, Darius J R Lane, Ashley I Bush, Scott Jonathan Ayton
Receptor-Independent Anti-Ferroptotic Activity of TrkB Modulators. International journal of molecular sciences 23 (24) (2022)
David Devos, Julien Labreuche, Olivier Rascol, Jean-Christophe Corvol, Alain Duhamel, Pauline Guyon Delannoy, Werner Poewe, Yaroslau Compta, Nicola Pavese, Evžen Růžička, Petr Dušek, Bart Post, Bastiaan R Bloem, Daniela Berg, Walter Maetzler, Markus Otto, Marie-Odile Habert, Stéphane Lehericy, Joaquim Ferreira, Richard Dodel, Christine Tranchant, Alexandre Eusebio, Stéphane Thobois, Ana-Raquel Marques, Wassilios G Meissner, Fabienne Ory-Magne, Uwe Walter, Rob M A de Bie, Miguel Gago, Dolores Vilas, Jaime Kulisevsky, Cristina Januario, Miguel V S Coelho, Stefanie Behnke, Paul Worth, Klaus Seppi, Thavarak Ouk, Camille Potey, Céline Leclercq, Romain Viard, Gregory Kuchcinski, Renaud Lopes, Jean-Pierre Pruvo, Pascal Pigny, Guillaume Garçon, Ophélie Simonin, Jessica Carpentier, Anne-Sophie Rolland, Dag Nyholm, Christoph Scherfler, Jean-François Mangin, Marie Chupin, Régis Bordet, David T Dexter, Caroline Fradette, Michael Spino, Fernando Tricta, Scott Jonathan Ayton, Ashley I Bush, Jean-Christophe Devedjian, James A Duce, Ioav Cabantchik, Luc Defebvre, Dominique Deplanque, Caroline Moreau, null null
Trial of Deferiprone in Parkinson's Disease. The New England journal of medicine 387 (22) (2022)
Md Jakaria, Abdel Ali Belaidi, Adam Southon, Krista A Dent, Darius J R Lane, Ashley I Bush, Scott Jonathan Ayton
Receptor-Independent Anti-Ferroptotic Activity of TrkB Modulators. International journal of molecular sciences 23 (24) (2022)
Md Jakaria, Abdel Ali Belaidi, Adam Southon, Krista A Dent, Darius J R Lane, Ashley I Bush, Scott Jonathan Ayton
Receptor-Independent Anti-Ferroptotic Activity of TrkB Modulators. International journal of molecular sciences 23 (24) (2022)
Scott Jonathan Ayton, Shorena Janelidze, Pawel Kalinowski, Sebastian Palmqvist, Abdel Ali Belaidi, Erik Stomrud, Anne Roberts, Blaine Roberts, Oskar Hansson, Ashley Ian Bush
CSF ferritin in the clinicopathological progression of Alzheimer's disease and associations with APOE and inflammation biomarkers. Journal of neurology, neurosurgery, and psychiatry (2022)
Md Jakaria, Abdel Ali Belaidi, Adam Southon, Krista A Dent, Darius J R Lane, Ashley I Bush, Scott Jonathan Ayton
Receptor-Independent Anti-Ferroptotic Activity of TrkB Modulators. International journal of molecular sciences 23 (24) (2022)
Mark A Greenough, Darius J R Lane, Rachelle Balez, Helena Targa Dias Anastacio, Zhiwen Zeng, Katherine Ganio, Christopher A McDevitt, Karla Acevedo, Abdel Ali Belaidi, Jari Koistinaho, Lezanne Ooi, Scott Jonathan Ayton, Ashley I Bush
Selective ferroptosis vulnerability due to familial Alzheimer's disease presenilin mutations. Cell death and differentiation 29 (11) (2022)
Scott Jonathan Ayton, Sara Hall, Shorena Janelidze, Pawel Kalinowski, Sebastian Palmqvist, Abdel A Belaidi, Blaine Roberts, Anne Roberts, Erik Stomrud, Ashley I Bush, Oskar Hansson
The Neuroinflammatory Acute Phase Response in Parkinsonian-Related Disorders. Movement disorders : official journal of the Movement Disorder Society 37 (5) (2022)
Puja Agarwal, Scott Jonathan Ayton, Sonal Agrawal, Klodian Dhana, David A Bennett, Lisa L Barnes, Sue E Leurgans, Ashley I Bush, Julie A Schneider
Brain copper may protect from cognitive decline and Alzheimer's disease pathology: a community-based study. Molecular psychiatry 27 (10) (2022)
Francesca M Alves, Kai Kysenius, Marissa K Caldow, Justin P Hardee, Jin D Chung, Jennifer Trieu, Dominic James Hare, Peter J Crouch, Scott Jonathan Ayton, Ashley I Bush, Gordon S Lynch, René Koopman
Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy. Journal of cachexia, sarcopenia and muscle 13 (3) (2022)
Scott Jonathan Ayton
Ventricular enlargement caused by aducanumab. Nature reviews. Neurology 18 (7) (2022)
Yu-Jie Guo, Scott Jonathan Ayton, Peng Lei
Iron reduces the propagation of pathological α-synuclein: An Editorial Highlight for "Brain iron enrichment attenuates α-synuclein spreading after injection of preformed fibrils" on page 554. Journal of neurochemistry 159 (3) (2021)
Francesca M Alves, Kai Kysenius, Marissa K Caldow, Justin P Hardee, Peter J Crouch, Scott Jonathan Ayton, Ashley I Bush, Gordon S Lynch, René Koopman
Iron accumulation in skeletal muscles of old mice is associated with impaired regeneration after ischaemia-reperfusion damage. Journal of cachexia, sarcopenia and muscle 12 (2) (2021)
Md Jakaria, Abdel Ali Belaidi, Ashley I Bush, Scott Jonathan Ayton
Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease. Journal of neurochemistry 159 (5) (2021)
Darius J R Lane, Billie Metselaar, Mark A Greenough, Ashley I Bush, Scott Jonathan Ayton
Ferroptosis and NRF2: an emerging battlefield in the neurodegeneration of Alzheimer's disease. Essays in biochemistry (2021)
Scott Jonathan Ayton
Brain volume loss due to donanemab. European journal of neurology 28 (9) (2021)
Andrew Gleason, Scott Jonathan Ayton, Ashley I Bush
Unblinded by the light: amyloid-related imaging abnormalities in Alzheimer's clinical trials. European journal of neurology 28 (1) (2020)
Adam Southon, Kathryn Szostak, Karla M Acevedo, Krista A Dent, Irene Volitakis, Abdel A Belaidi, Kevin J Barnham, Peter J Crouch, Scott Jonathan Ayton, Paul S Donnelly, Ashley I Bush
CuII (atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease. British journal of pharmacology 177 (3) (2020)
Shashank Masaldan, Abdel Ali Belaidi, Scott Jonathan Ayton, Ashley I Bush
Cellular Senescence and Iron Dyshomeostasis in Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland) 12 (2) (2019)
Sara Nikseresht, Ashley I Bush, Scott Jonathan Ayton
Treating Alzheimer's disease by targeting iron. British journal of pharmacology 176 (18) (2019)
Denzil Furtado, Mattias Björnmalm, Scott Jonathan Ayton, Ashley I Bush, Kristian Kempe, Frank Caruso
Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases. Advanced materials (Deerfield Beach, Fla.) 30 (46) (2018)
Scott Jonathan Ayton, Peng Lei, Catriona Mclean, Ashley I Bush, David I Finkelstein
Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson's substantia nigra. Signal transduction and targeted therapy 1 (2016)
Laura Mahoney-Sanchez, Abdel Ali Belaidi, Ashley I Bush, Scott Jonathan Ayton
The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update. Journal of molecular neuroscience : MN 60 (3) (2016)
Scott Jonathan Ayton, Peng Lei, Dominic James Hare, James A Duce, Jessica L George, Paul A Adlard, Catriona McLean, Jack T Rogers, Robert A Cherny, David I Finkelstein, Ashley I Bush
Parkinson's disease iron deposition caused by nitric oxide-induced loss of β-amyloid precursor protein. The Journal of neuroscience : the official journal of the Society for Neuroscience 35 (8) (2015)
Scott Jonathan Ayton, Noel G Faux, Ashley I Bush, null null
Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE. Nature communications 6 (2015)
Scott Jonathan Ayton, Peng Lei
Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration. BioMed research international 2014 (2014)